Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2019

01-12-2019 | Affective Disorder | Viewpoint

Accountable Care Organizations’ Performance in Depression: Lessons for Value-Based Payment and Behavioral Health

Authors: Nathaniel Z Counts, JD, Glenda Wrenn, MD, MSHP, David Muhlestein, PhD, JD

Published in: Journal of General Internal Medicine | Issue 12/2019

Login to get access

Abstract

Value-based payment initiatives, such as the Medicare Shared Savings Program (MSSP), offer the possibility of using financial incentives to drive improvements in mental health and substance use outcomes. In the past 2 years, Accountable Care Organizations (ACOs) participating in the MSSP began to publicly report on one behavioral health outcome—Depression Remission at Twelve Months, which may indicate how value-based payment incentives have impacted mental health and substance use, and if reforms are needed. For ACOs that meaningfully reported performance on the depression remission measure in 2017, the median rate of depression remission at 12 months was 8.33%. A recent meta-analysis found that the average rate of spontaneous depression remission at 12 months absent treatment was approximately 53%. Although a number of factors likely explain these results, the current ACO design does not appear to incentivize improved behavioral health outcomes. Four changes in value-based payment incentive design may help to drive better outcomes: (1) making data collection easier, (2) increasing the salience of incentives, (3) building capacity to implement new interventions, and (4) creating safeguards for inappropriate treatment or reporting.
Literature
1.
go back to reference Busch AB, Huskamp HA, McWilliams JM. Early efforts by Medicare accountable care organizations have limited effect on mental illness care and management. Health Affairs. 2016 Jul 1;35(7):1247–56.CrossRef Busch AB, Huskamp HA, McWilliams JM. Early efforts by Medicare accountable care organizations have limited effect on mental illness care and management. Health Affairs. 2016 Jul 1;35(7):1247–56.CrossRef
2.
go back to reference Pincus HA, Scholle SH, Spaeth-Rublee B, Hepner KA, Brown J. Quality measures for mental health and substance use: gaps, opportunities, and challenges. Health Affairs. 2016 Jun 1;35(6):1000–8.CrossRef Pincus HA, Scholle SH, Spaeth-Rublee B, Hepner KA, Brown J. Quality measures for mental health and substance use: gaps, opportunities, and challenges. Health Affairs. 2016 Jun 1;35(6):1000–8.CrossRef
3.
go back to reference Whiteford HA, Harris MG, McKeon G, Baxter A, Pennell C, Barendregt JJ, Wang J. Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychological medicine. 2013 Aug;43(8):1569–85.CrossRef Whiteford HA, Harris MG, McKeon G, Baxter A, Pennell C, Barendregt JJ, Wang J. Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychological medicine. 2013 Aug;43(8):1569–85.CrossRef
4.
go back to reference Fortney JC, Unützer J, Wrenn G, Pyne JM, Smith GR, Schoenbaum M, Harbin HT. A tipping point for measurement-based care. Psychiatric Services. 2016 Sep 1;68(2):179–88.CrossRef Fortney JC, Unützer J, Wrenn G, Pyne JM, Smith GR, Schoenbaum M, Harbin HT. A tipping point for measurement-based care. Psychiatric Services. 2016 Sep 1;68(2):179–88.CrossRef
5.
go back to reference Marcotte L, Hodlofski A, Bond A, Patel P, Sacks L, Navathe AS. Into practice: How Advocate Health System uses behavioral economics to motivate physicians in its incentive program. Healthcare 2017 Sep 1;5(3): 129–135.CrossRef Marcotte L, Hodlofski A, Bond A, Patel P, Sacks L, Navathe AS. Into practice: How Advocate Health System uses behavioral economics to motivate physicians in its incentive program. Healthcare 2017 Sep 1;5(3): 129–135.CrossRef
6.
go back to reference Dennehy EB, Robinson RL, Stephenson JJ, Faries D, Grabner M, Palli SR, Stauffer VL, Marangell LB. Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study. Current medical research and opinion. 2015 Jun 3;31(6):1165–77.CrossRef Dennehy EB, Robinson RL, Stephenson JJ, Faries D, Grabner M, Palli SR, Stauffer VL, Marangell LB. Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study. Current medical research and opinion. 2015 Jun 3;31(6):1165–77.CrossRef
Metadata
Title
Accountable Care Organizations’ Performance in Depression: Lessons for Value-Based Payment and Behavioral Health
Authors
Nathaniel Z Counts, JD
Glenda Wrenn, MD, MSHP
David Muhlestein, PhD, JD
Publication date
01-12-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05047-x

Other articles of this Issue 12/2019

Journal of General Internal Medicine 12/2019 Go to the issue